메뉴 건너뛰기




Volumn 8, Issue 10, 2013, Pages

Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; INTERFERON; INTERFERON REGULATORY FACTOR; VON HIPPEL LINDAU PROTEIN;

EID: 84885062989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076746     Document Type: Article
Times cited : (44)

References (55)
  • 1
    • 80052270947 scopus 로고    scopus 로고
    • The epidemiology of renal cell carcinoma
    • doi:10.1016/j.eururo.2011.06.049
    • Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, et al. (2011) The epidemiology of renal cell carcinoma. Eur Urol 60: 615-621. doi:10.1016/j.eururo.2011.06.049. PubMed: 21741761.
    • (2011) Eur Urol , vol.60 , pp. 615-621
    • Ljungberg, B.1    Campbell, S.C.2    Choi, H.Y.3    Jacqmin, D.4    Lee, J.E.5
  • 2
    • 0031255567 scopus 로고    scopus 로고
    • The Heidelberg classification of renal cell tumours
    • doi:10.1002/(SICI)1096-9896(199710)183:2
    • Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, et al. (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133. doi:10.1002/(SICI)1096-9896(199710)183:2. PubMed: 9390023.
    • (1997) J Pathol , vol.183 , pp. 131-133
    • Kovacs, G.1    Akhtar, M.2    Beckwith, B.J.3    Bugert, P.4    Cooper, C.S.5
  • 3
    • 0030853434 scopus 로고    scopus 로고
    • Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
    • doi:10.1002/(SICI)1097-0142(19970901)80:5
    • Störkel S, Eble JN, Adlakha K, Amin M, Blute ML, et al. (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 987-989. doi:10.1002/(SICI)1097-0142(19970901)80:5. PubMed: 9307203.
    • (1997) Cancer , vol.80 , pp. 987-989
    • Störkel, S.1    Eble, J.N.2    Adlakha, K.3    Amin, M.4    Blute, M.L.5
  • 4
    • 78649347932 scopus 로고    scopus 로고
    • Evaluation and management of the renal mass
    • doi:10.1016/j.mcna.2010.08.021
    • Chen DY, Uzzo RG, (2011) Evaluation and management of the renal mass. Med Clin North Am 95: 179-189. doi:10.1016/j.mcna.2010.08.021. PubMed: 21095421.
    • (2011) Med Clin North Am , vol.95 , pp. 179-189
    • Chen, D.Y.1    Uzzo, R.G.2
  • 5
    • 77955635233 scopus 로고    scopus 로고
    • Cancer statistics, 2010
    • doi:10.3322/caac.20073
    • Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300. doi:10.3322/caac.20073. PubMed: 20610543.
    • (2010) CA Cancer J Clin , vol.60 , pp. 277-300
    • Jemal, A.1    Siegel, R.2    Xu, J.3    Ward, E.4
  • 6
    • 65949091346 scopus 로고    scopus 로고
    • Targeting mTOR in renal cell carcinoma
    • doi:10.1002/cncr.24239
    • Hudes GR, (2009) Targeting mTOR in renal cell carcinoma. Cancer 115: 2313-2320. doi:10.1002/cncr.24239. PubMed: 19402072.
    • (2009) Cancer , vol.115 , pp. 2313-2320
    • Hudes, G.R.1
  • 7
    • 77957997621 scopus 로고    scopus 로고
    • Targeted therapies for renal cell carcinoma: understanding their impact on survival
    • doi:10.1007/s11523-010-0145-6
    • Pal SK, Figlin RA, (2010) Targeted therapies for renal cell carcinoma: understanding their impact on survival. Target Oncol 5: 131-138. doi:10.1007/s11523-010-0145-6. PubMed: 20632214.
    • (2010) Target Oncol , vol.5 , pp. 131-138
    • Pal, S.K.1    Figlin, R.A.2
  • 8
    • 79955689582 scopus 로고    scopus 로고
    • Targeted-therapy in advanced renal cell carcinoma
    • doi:10.2174/092986711795471293
    • Pirrotta MT, Bernardeschi P, Fiorentini G, (2011) Targeted-therapy in advanced renal cell carcinoma. Curr Med Chem 18: 1651-1657. doi:10.2174/092986711795471293. PubMed: 21428882.
    • (2011) Curr Med Chem , vol.18 , pp. 1651-1657
    • Pirrotta, M.T.1    Bernardeschi, P.2    Fiorentini, G.3
  • 9
    • 84856159566 scopus 로고    scopus 로고
    • Targeted therapies for renal cell carcinoma: review of adverse event management strategies
    • doi:10.1093/jnci/djr511
    • Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, et al. (2012) Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104: 93-113. doi:10.1093/jnci/djr511. PubMed: 22235142.
    • (2012) J Natl Cancer Inst , vol.104 , pp. 93-113
    • Eisen, T.1    Sternberg, C.N.2    Robert, C.3    Mulders, P.4    Pyle, L.5
  • 10
    • 77952263737 scopus 로고    scopus 로고
    • The genetic basis of kidney cancer: a metabolic disease
    • doi:10.1038/nrurol.2010.47
    • Linehan WM, Srinivasan R, Schmidt LS, (2010) The genetic basis of kidney cancer: a metabolic disease. Nat. Rev Urol 7: 277-285. doi:10.1038/nrurol.2010.47.
    • (2010) Nat Rev Urol , vol.7 , pp. 277-285
    • Linehan, W.M.1    Srinivasan, R.2    Schmidt, L.S.3
  • 11
    • 2942689618 scopus 로고    scopus 로고
    • The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
    • doi:10.1152/ajpheart.00952.2003
    • Sufan RI, Jewett MA, Ohh M, (2004) The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma. Am J Physiol Renal Physiol 287: F1-F6. doi:10.1152/ajpheart.00952.2003. PubMed: 15180922.
    • (2004) Am J Physiol Renal Physiol , vol.287
    • Sufan, R.I.1    Jewett, M.A.2    Ohh, M.3
  • 12
    • 45249124315 scopus 로고    scopus 로고
    • Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor
    • doi:10.1042/BST0360472
    • Nyhan MJ, O'Sullivan GC, McKenna SL, (2008) Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor. Biochem Soc Trans 36: 472-478. doi:10.1042/BST0360472. PubMed: 18481984.
    • (2008) Biochem Soc Trans , vol.36 , pp. 472-478
    • Nyhan, M.J.1    O'Sullivan, G.C.2    McKenna, S.L.3
  • 13
    • 84861845402 scopus 로고    scopus 로고
    • The updated biology of hypoxia-inducible factor
    • doi:10.1038/emboj.2012.125
    • Greer SN, Metcalf JL, Wang Y, Ohh M, (2012) The updated biology of hypoxia-inducible factor. EMBO J 31: 2448-2460. doi:10.1038/emboj.2012.125. PubMed: 22562152.
    • (2012) EMBO J , vol.31 , pp. 2448-2460
    • Greer, S.N.1    Metcalf, J.L.2    Wang, Y.3    Ohh, M.4
  • 14
    • 80053357273 scopus 로고    scopus 로고
    • The emerging role of nuclear factor kappa B in renal cell carcinoma
    • doi:10.1016/j.biocel.2011.08.003
    • Morais C, Gobe G, Johnson DW, Healy H, (2011) The emerging role of nuclear factor kappa B in renal cell carcinoma. Int J Biochem Cell Biol 43: 1537-1549. doi:10.1016/j.biocel.2011.08.003. PubMed: 21854869.
    • (2011) Int J Biochem Cell Biol , vol.43 , pp. 1537-1549
    • Morais, C.1    Gobe, G.2    Johnson, D.W.3    Healy, H.4
  • 15
    • 0242694963 scopus 로고    scopus 로고
    • The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway
    • Qi H, Ohh M, (2003) The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kappaB-dependent antiapoptotic pathway. Cancer Res 63: 7076-7080. PubMed: 14612498.
    • (2003) Cancer Res , vol.63 , pp. 7076-7080
    • Qi, H.1    Ohh, M.2
  • 16
    • 23844527189 scopus 로고    scopus 로고
    • Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity
    • doi:10.1128/MCB.25.17.7546-7556.2005
    • An J, Rettig MB, (2005) Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity. Mol Cell Biol 25: 7546-7556. doi:10.1128/MCB.25.17.7546-7556.2005. PubMed: 16107702.
    • (2005) Mol Cell Biol , vol.25 , pp. 7546-7556
    • An, J.1    Rettig, M.B.2
  • 17
    • 34948883495 scopus 로고    scopus 로고
    • pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2
    • doi:10.1016/j.molcel.2007.09.010
    • Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, et al. (2007) pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell 28: 15-27. doi:10.1016/j.molcel.2007.09.010. PubMed: 17936701.
    • (2007) Mol Cell , vol.28 , pp. 15-27
    • Yang, H.1    Minamishima, Y.A.2    Yan, Q.3    Schlisio, S.4    Ebert, B.L.5
  • 18
    • 33846805694 scopus 로고    scopus 로고
    • Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib
    • doi:10.1186/1476-4598-6-61
    • An J, Rettig MB, (2007) Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib. Mol Cancer Ther 6: 61-69. doi:10.1186/1476-4598-6-61. PubMed: 17237266.
    • (2007) Mol Cancer Ther , vol.6 , pp. 61-69
    • An, J.1    Rettig, M.B.2
  • 19
    • 44049107707 scopus 로고    scopus 로고
    • Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
    • doi:10.1093/jnci/djn113
    • Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, et al. (2008) Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst 100: 649-662. doi:10.1093/jnci/djn113. PubMed: 18445820.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 649-662
    • Shanker, A.1    Brooks, A.D.2    Tristan, C.A.3    Wine, J.W.4    Elliott, P.J.5
  • 20
    • 77952944929 scopus 로고    scopus 로고
    • Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex
    • doi:10.1158/1541-7786.MCR-10-0022
    • Brooks AD, Jacobsen KM, Li W, Shanker A, Sayers TJ, (2010) Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Mol Cancer Res 8: 729-738. doi:10.1158/1541-7786.MCR-10-0022. PubMed: 20442297.
    • (2010) Mol Cancer Res , vol.8 , pp. 729-738
    • Brooks, A.D.1    Jacobsen, K.M.2    Li, W.3    Shanker, A.4    Sayers, T.J.5
  • 21
    • 77956929126 scopus 로고    scopus 로고
    • Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus
    • Roos FC, Roberts AM, Hwang II, Moriyama EH, Evans AJ, et al. (2010) Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus. EMBO. Mol Med 2: 275-288.
    • (2010) EMBO Mol Med , vol.2 , pp. 275-288
    • Roos, F.C.1    Roberts, A.M.2    Hwang, I.I.3    Moriyama, E.H.4    Evans, A.J.5
  • 22
    • 0142121516 scopus 로고    scopus 로고
    • Exploration, normalization, and summaries of high density oligonucleotide array probe level data
    • doi:10.1093/biostatistics/4.2.249
    • Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. doi:10.1093/biostatistics/4.2.249. PubMed: 12925520.
    • (2003) Biostatistics , vol.4 , pp. 249-264
    • Irizarry, R.A.1    Hobbs, B.2    Collin, F.3    Beazer-Barclay, Y.D.4    Antonellis, K.J.5
  • 23
    • 28744458859 scopus 로고    scopus 로고
    • Bioconductor: open software development for computational biology and bioinformatics
    • doi:10.1186/gb-2004-5-10-r80
    • Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:10.1186/gb-2004-5-10-r80. PubMed: 15461798.
    • (2004) Genome Biol , vol.5
    • Gentleman, R.C.1    Carey, V.J.2    Bates, D.M.3    Bolstad, B.4    Dettling, M.5
  • 24
    • 33751006151 scopus 로고    scopus 로고
    • RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis
    • doi:10.1093/bioinformatics/btl476
    • Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827. doi:10.1093/bioinformatics/btl476. PubMed: 16982708.
    • (2006) Bioinformatics , vol.22 , pp. 2825-2827
    • Hong, F.1    Breitling, R.2    McEntee, C.W.3    Wittner, B.S.4    Nemhauser, J.L.5
  • 25
    • 4544341015 scopus 로고    scopus 로고
    • Linear models and empirical bayes methods for assessing differential expression in microarray experiments
    • Article3
    • Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3Article3 PubMed: 16646809.
    • (2004) Stat Appl Genet Mol Biol , vol.3
    • Smyth, G.K.1
  • 26
    • 77958075147 scopus 로고    scopus 로고
    • A semi-parametric generalization of the Cox proportional hazards regression model: Inference and Applications
    • doi:10.1016/j.csda.2010.06.010
    • Devarajan K, Ebrahimi N, (2011) A semi-parametric generalization of the Cox proportional hazards regression model: Inference and Applications. Comput Stat Data Anal 55: 667-676. doi:10.1016/j.csda.2010.06.010. PubMed: 21076652.
    • (2011) Comput Stat Data Anal , vol.55 , pp. 667-676
    • Devarajan, K.1    Ebrahimi, N.2
  • 27
    • 70449647008 scopus 로고
    • Proportional hazards tests and diagnostics based on weighted residuals
    • doi:10.1093/biomet/81.3.515
    • Grambsch PM, Therneau TM, (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526. doi:10.1093/biomet/81.3.515.
    • (1994) Biometrika , vol.81 , pp. 515-526
    • Grambsch, P.M.1    Therneau, T.M.2
  • 28
    • 0027080802 scopus 로고
    • The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis
    • doi:10.1002/sim.4780111409
    • Wei LJ, (1992) The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. Stat Med 11: 1871-1879. doi:10.1002/sim.4780111409. PubMed: 1480879.
    • (1992) Stat Med , vol.11 , pp. 1871-1879
    • Wei, L.J.1
  • 29
    • 33644972271 scopus 로고    scopus 로고
    • On least-squares regression with censored data
    • doi:10.1093/biomet/93.1.147
    • Jin Z, Lin DY, Ying Z, (2006) On least-squares regression with censored data. Biometrika 93: 147-161. doi:10.1093/biomet/93.1.147.
    • (2006) Biometrika , vol.93 , pp. 147-161
    • Jin, Z.1    Lin, D.Y.2    Ying, Z.3
  • 30
    • 84882256047 scopus 로고    scopus 로고
    • NF-kappaB Inhibition by Bortezomib Permits Interferon-gamma-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma
    • Thapa RJ, Chen P, Cheung M, Nogusa S, Pei J, et al. (2013) NF-kappaB Inhibition by Bortezomib Permits Interferon-gamma-Activated RIP1 Kinase-Dependent Necrosis in Renal Cell Carcinoma. Mol Cancer Ther.
    • (2013) Mol Cancer Ther
    • Thapa, R.J.1    Chen, P.2    Cheung, M.3    Nogusa, S.4    Pei, J.5
  • 31
    • 34548071005 scopus 로고    scopus 로고
    • Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma
    • doi:10.1158/1078-0432.CCR-07-0143
    • Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, et al. (2007) Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13: 4740-4749. doi:10.1158/1078-0432.CCR-07-0143. PubMed: 17699851.
    • (2007) Clin Cancer Res , vol.13 , pp. 4740-4749
    • Gumz, M.L.1    Zou, H.2    Kreinest, P.A.3    Childs, A.C.4    Belmonte, L.S.5
  • 32
    • 0344406232 scopus 로고    scopus 로고
    • Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma
    • doi:10.1093/carcin/24.3.377
    • Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, et al. (2003) Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24: 377-384. doi:10.1093/carcin/24.3.377. PubMed: 12663495.
    • (2003) Carcinogenesis , vol.24 , pp. 377-384
    • Oya, M.1    Takayanagi, A.2    Horiguchi, A.3    Mizuno, R.4    Ohtsubo, M.5
  • 33
    • 14944366562 scopus 로고    scopus 로고
    • VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism
    • doi:10.1038/sj.onc.1208348
    • An J, Fisher M, Rettig MB, (2005) VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism. Oncogene 24: 1563-1570. doi:10.1038/sj.onc.1208348. PubMed: 15608669.
    • (2005) Oncogene , vol.24 , pp. 1563-1570
    • An, J.1    Fisher, M.2    Rettig, M.B.3
  • 34
    • 4444376712 scopus 로고    scopus 로고
    • Signaling to NF-kappaB
    • doi:10.1101/gad.1228704
    • Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224. doi:10.1101/gad.1228704. PubMed: 15371334.
    • (2004) Genes Dev , vol.18 , pp. 2195-2224
    • Hayden, M.S.1    Ghosh, S.2
  • 35
    • 0033596121 scopus 로고    scopus 로고
    • Activators and target genes of Rel/NF-kappaB transcription factors
    • doi:10.1038/sj.onc.1203239
    • Pahl HL, (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866. doi:10.1038/sj.onc.1203239. PubMed: 10602461.
    • (1999) Oncogene , vol.18 , pp. 6853-6866
    • Pahl, H.L.1
  • 36
    • 79952384759 scopus 로고    scopus 로고
    • Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses
    • doi:10.1128/JVI.02213-10
    • Basagoudanavar SH, Thapa RJ, Nogusa S, Wang J, Beg AA, et al. (2011) Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses. J Virol 85: 2599-2610. doi:10.1128/JVI.02213-10. PubMed: 21209118.
    • (2011) J Virol , vol.85 , pp. 2599-2610
    • Basagoudanavar, S.H.1    Thapa, R.J.2    Nogusa, S.3    Wang, J.4    Beg, A.A.5
  • 37
    • 79960363668 scopus 로고    scopus 로고
    • NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis
    • doi:10.1128/MCB.05445-11
    • Thapa RJ, Basagoudanavar SH, Nogusa S, Irrinki K, Mallilankaraman K, et al. (2011) NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol Cell Biol 31: 2934-2946. doi:10.1128/MCB.05445-11. PubMed: 21576359.
    • (2011) Mol Cell Biol , vol.31 , pp. 2934-2946
    • Thapa, R.J.1    Basagoudanavar, S.H.2    Nogusa, S.3    Irrinki, K.4    Mallilankaraman, K.5
  • 38
    • 39749116278 scopus 로고    scopus 로고
    • Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
    • doi:10.1186/1476-4598-7-6
    • Cifola I, Spinelli R, Beltrame L, Peano C, Fasoli E, et al. (2008) Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer 7: 6. doi:10.1186/1476-4598-7-6. PubMed: 18194544.
    • (2008) Mol Cancer , vol.7 , pp. 6
    • Cifola, I.1    Spinelli, R.2    Beltrame, L.3    Peano, C.4    Fasoli, E.5
  • 39
    • 3042752912 scopus 로고    scopus 로고
    • Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data
    • doi:10.1186/1471-2407-3-31
    • Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, et al. (2003) Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data. BMC Cancer 3: 31. doi:10.1186/1471-2407-3-31. PubMed: 14641932.
    • (2003) BMC Cancer , vol.3 , pp. 31
    • Lenburg, M.E.1    Liou, L.S.2    Gerry, N.P.3    Frampton, G.M.4    Cohen, H.T.5
  • 40
    • 66749104378 scopus 로고    scopus 로고
    • High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
    • doi:10.1186/1471-2407-9-152
    • Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, et al. (2009) High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9: 152. doi:10.1186/1471-2407-9-152. PubMed: 19445733.
    • (2009) BMC Cancer , vol.9 , pp. 152
    • Yusenko, M.V.1    Kuiper, R.P.2    Boethe, T.3    Ljungberg, B.4    van Kessel, A.G.5
  • 41
    • 0036467492 scopus 로고    scopus 로고
    • The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors
    • doi:10.1016/S0952-7915(01)00305-3
    • Taniguchi T, Takaoka A, (2002) The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14: 111-116. doi:10.1016/S0952-7915(01)00305-3. PubMed: 11790540.
    • (2002) Curr Opin Immunol , vol.14 , pp. 111-116
    • Taniguchi, T.1    Takaoka, A.2
  • 42
    • 84876575052 scopus 로고    scopus 로고
    • Interferome v2.0: an updated database of annotated interferon-regulated genes
    • Rusinova I, Forster S, Yu S, Kannan A, Masse M, et al. (2012) Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41: D1040-D1046. PubMed: 23203888.
    • (2012) Nucleic Acids Res , vol.41
    • Rusinova, I.1    Forster, S.2    Yu, S.3    Kannan, A.4    Masse, M.5
  • 43
    • 33846933267 scopus 로고    scopus 로고
    • Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7
    • Balachandran S, Venkataraman T, Fisher PB, Barber GN, (2007) Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 178: 2429-2439. PubMed: 17277150.
    • (2007) J Immunol , vol.178 , pp. 2429-2439
    • Balachandran, S.1    Venkataraman, T.2    Fisher, P.B.3    Barber, G.N.4
  • 44
    • 80055092195 scopus 로고    scopus 로고
    • Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm
    • Balachandran S, Beg AA, (2011) Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm. PLOS Pathog 7: e1002165.
    • (2011) PLOS Pathog , vol.7
    • Balachandran, S.1    Beg, A.A.2
  • 45
    • 0035344461 scopus 로고    scopus 로고
    • A weak signal for strong responses: interferon-alpha/beta revisited
    • doi:10.1038/35073080
    • Taniguchi T, Takaoka A, (2001) A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386. doi:10.1038/35073080. PubMed: 11331912.
    • (2001) Nat Rev Mol Cell Biol , vol.2 , pp. 378-386
    • Taniguchi, T.1    Takaoka, A.2
  • 46
    • 84857415635 scopus 로고    scopus 로고
    • Constitutive type I interferon modulates homeostatic balance through tonic signaling
    • doi:10.1016/j.immuni.2012.01.011
    • Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE, (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174. doi:10.1016/j.immuni.2012.01.011. PubMed: 22365663.
    • (2012) Immunity , vol.36 , pp. 166-174
    • Gough, D.J.1    Messina, N.L.2    Clarke, C.J.3    Johnstone, R.W.4    Levy, D.E.5
  • 48
    • 22344432068 scopus 로고    scopus 로고
    • Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations
    • doi:10.4161/cbt.3.12.1459
    • Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, et al. (2004) Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biol Ther 3: 1313-1321. doi:10.4161/cbt.3.12.1459. PubMed: 15662135.
    • (2004) Cancer Biol Ther , vol.3 , pp. 1313-1321
    • Stoyanova, R.1    Clapper, M.L.2    Bellacosa, A.3    Henske, E.P.4    Testa, J.R.5
  • 49
    • 66349100709 scopus 로고    scopus 로고
    • Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney
    • doi:10.1158/0008-5472.CAN-09-0146
    • Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, et al. (2009) Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 69: 4674-4681. doi:10.1158/0008-5472.CAN-09-0146. PubMed: 19470766.
    • (2009) Cancer Res , vol.69 , pp. 4674-4681
    • Beroukhim, R.1    Brunet, J.P.2    Di Napoli, A.3    Mertz, K.D.4    Seeley, A.5
  • 50
    • 58149202128 scopus 로고    scopus 로고
    • Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls
    • doi:10.1038/nrd2781
    • Baud V, Karin M, (2009) Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40. doi:10.1038/nrd2781. PubMed: 19116625.
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 33-40
    • Baud, V.1    Karin, M.2
  • 51
    • 80052014052 scopus 로고    scopus 로고
    • Inflammation meets cancer, with NF-kappaB as the matchmaker
    • doi:10.1038/ni.2060
    • Ben-Neriah Y, Karin M, (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12: 715-723. doi:10.1038/ni.2060. PubMed: 21772280.
    • (2011) Nat Immunol , vol.12 , pp. 715-723
    • Ben-Neriah, Y.1    Karin, M.2
  • 52
    • 33750432183 scopus 로고    scopus 로고
    • Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression
    • doi:10.1038/sj.onc.1209942
    • Bassères DS, Baldwin AS, (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25: 6817-6830. doi:10.1038/sj.onc.1209942. PubMed: 17072330.
    • (2006) Oncogene , vol.25 , pp. 6817-6830
    • Bassères, D.S.1    Baldwin, A.S.2
  • 53
    • 0029617947 scopus 로고
    • Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
    • doi:10.1016/0092-8674(95)90136-1
    • Thanos D, Maniatis T, (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100. doi:10.1016/0092-8674(95)90136-1. PubMed: 8548797.
    • (1995) Cell , vol.83 , pp. 1091-1100
    • Thanos, D.1    Maniatis, T.2
  • 54
    • 0037053327 scopus 로고    scopus 로고
    • Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility
    • doi:10.1074/jbc.M111440200
    • Lu R, Moore PA, Pitha PM, (2002) Stimulation of IRF-7 gene expression by tumor necrosis factor alpha: requirement for NFkappa B transcription factor and gene accessibility. J Biol Chem 277: 16592-16598. doi:10.1074/jbc.M111440200. PubMed: 11877397.
    • (2002) J Biol Chem , vol.277 , pp. 16592-16598
    • Lu, R.1    Moore, P.A.2    Pitha, P.M.3
  • 55
    • 17144404177 scopus 로고    scopus 로고
    • IRF-7 is the master regulator of type-I interferon-dependent immune responses
    • doi:10.1038/nature03464
    • Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. doi:10.1038/nature03464. PubMed: 15800576.
    • (2005) Nature , vol.434 , pp. 772-777
    • Honda, K.1    Yanai, H.2    Negishi, H.3    Asagiri, M.4    Sato, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.